Patient Guide: Clinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in the First-line Treatment of Metastatic Pancreatic Neoplasms

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 7 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06767813
Status: 🟢 Enrolling Now
Condition: Pancreatic Neoplasms
Phase: PHASE2

Where You Can Participate

This study is available at 7 locations across the country.

Top locations include:
  • • Zhengzhou, Henan
  • • Zhengzhou, Henan
  • • Nanjing, Jiangsu
  • • And 4 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Clinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in the First-line Treatment of Metastatic Pancreatic Neoplasms - Join Clinical Trial NCTNCT06767813

How to Join This Clinical Trial - NCTNCT06767813

Learn how to participate in this PHASE2 trial studying an investigational therapy for Pancreatic Neoplasms. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Pancreatic Neoplasms. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Pancreatic Neoplasms
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06767813 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 7 locations. Find a study site near you:

Clinical Research Site

Zhengzhou, Henan 450000 - China

Status: RECRUITING

Clinical Research Site

Zhengzhou, Henan 450039 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Nanjing, Jiangsu 210000 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Nanjing, Jiangsu 210000 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Suzhou, Jiangsu 215006 - China

Status: NOT_YET_RECRUITING

Clinical Research Site

Shanghai, Shanghai Municipality 200032 - China

Status: RECRUITING

Clinical Research Site

Wenzhou, Zhejiang 325000 - China

Status: NOT_YET_RECRUITING

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Pancreatic Neoplasms:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships